Futura Medical Share Chat (FUM)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Futura Medical Plc	LSE:FUM	London	Ordinary Share	GB0033278473	ORD 0.2P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.75p	-1.61%	45.75p	45.00p	46.50p	47.25p	44.75p	46.50p	775,178	14:18:25

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-7.2	-4.5	-	94

Futura Medical Share Discussion Threads

Showing 16851 to 16875 of 17100 messages

Chat Pages: 684 683 682 681 680 679 678 677 676 675 674 673 Older

Date	Subject	Author	Discuss
10/6/2019 18:27	Well hopefully like the rest of us they will learn.	j777j	Read Full Thread Reply
10/6/2019 16:43	'management' is not Futura's forte !	mikethebike4	Read Full Thread Reply
10/6/2019 16:21	Many bags, over time, I am holding for a few years initially. In the short term a break through 28p will be significant and opens up a larger move to 40’s Good to see some press coverage Still under the radar, good chance to get in early. Reminds me when I was the only one on the (STX) thread accumulating in late 20’s & 30’s, now 110p+ I have been doing the same with (MSYS), on the pull back to 1p, just have to dyor and trust these Companies have solid management to deliver going fwd GL	ny boy	Read Full Thread Reply
10/6/2019 16:19	Multibagger staring us in the face. The market size is massive.	j777j	Read Full Thread Reply
10/6/2019 16:00	That article reads like scripted PR.	glavey	Read Full Thread Reply
10/6/2019 15:23	Futura Medical PLC (LON:FUM) saw its shares shoot higher on Monday after ‘house’ broker Liberum Capital highlighted an article published in ‘The Guardian’ newspaper which could spark interest in the group’s main product. In a note to clients, the City broker’s analysts pointed out that over the weekend the newspaper published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on the AIM-listed firm’s MED2005 which is in a P3 study due to read-out by the end of the year. They said: “The article highlights the lack of clinical advances in ED over the past 20 years and the emerging opportunity for products that can address the shortcomings of the PDe-5 inhibitor class (Viagra) with MED2005 appearing to offer convenience and side-effect profile benefits.” The analysts concluded: “This will help to drive interest in what appears to be a very over-looked product in terms of its potential to address a very large market	j777j	Read Full Thread Reply
10/6/2019 11:39	How many bags do you see here going forward?	j777j	Read Full Thread Reply
10/6/2019 08:31	Yep, it’s why we are invested for the long term, should bounce nicely off support here, buy with confidence imo but dyor	ny boy	Read Full Thread Reply
10/6/2019 08:24	Even if Futura only gets 20% of that,a 15% royalty is still $54 million a year.Amazing potential.	j777j	Read Full Thread Reply
10/6/2019 07:38	"Within three months of its launch, Viagra had already earned Pfizer $400m, and over the past two decades, it has consistently generated annual sales to the tune of $1.8bn."	j777j	Read Full Thread Reply
09/6/2019 10:24	From 1989, using patches: hTTps://www.karger.com/Article/Abstract/281528	rrr	Read Full Thread Reply
09/6/2019 10:23	Interesting how far back this idea goes - this from 1990 uses a paste: hTTps://www.ncbi.nlm.nih.gov/pubmed/2107336?dopt=Abstract	rrr	Read Full Thread Reply
09/6/2019 09:32	Great article kd, many thanks.	rrr	Read Full Thread Reply
09/6/2019 07:45	guardian webiste- The race to replace Viagra https://www.theguardian.com/science/2019/jun/09/race-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon	keifer derrin	Read Full Thread Reply
07/6/2019 13:29	Im still in hear quite heavily and comfortable with it. Trying not to look too often as it will be a bit of a slow burn until later in the year with fee mm shenanagans in between.	ragnarr	Read Full Thread Reply
07/6/2019 13:20	Buyers back in !!	dickiebird2	Read Full Thread Reply
07/6/2019 12:20	certainly 'bottom testing' !	mikethebike4	Read Full Thread Reply
06/6/2019 16:20	Testing the bottom of the up trend channel, if it holds, it should do well from here.	ny boy	Read Full Thread Reply
06/6/2019 15:25	I expect some dip buying over the next week or so, before a break to new highs	ny boy	Read Full Thread Reply
06/6/2019 15:11	Everyone sold out ? I guess no long term investors left then lol! (MSYS) is the next big thing imo but dyor!	ny boy	Read Full Thread Reply
29/5/2019 11:24	Anyone joining the MAIS shareholder action group?	kemche	Read Full Thread Reply
29/5/2019 10:52	LO selling again Good luck ... placing coming	ayesha4	Read Full Thread Reply
24/5/2019 12:11	You are not wrong there Global Erectile Dysfunction Drugs Market Will Reach USD 7.10 Billion by 2024: Zion Market Research According to the report, global erectile dysfunction drugs market was valued at approximately USD 4.82 billion in 2017 and is expected to generate revenue of around USD 7.10 billion by end of 2024, growing at a CAGR of around 5.70% between 2018 and 2024.	ragnarr	Read Full Thread Reply
24/5/2019 10:51	Not surprising when you consider the upside.	j777j	Read Full Thread Reply
24/5/2019 10:40	some quite hefty buys today - 50k, 100k, 250k - somebody must be taking an interest	mikethebike4	Read Full Thread Reply

Chat Pages: 684 683 682 681 680 679 678 677 676 675 674 673 Older